| Product NDC: | 0062-5356 |
| Proprietary Name: | Terazol 3 |
| Non Proprietary Name: | TERCONAZOLE |
| Active Ingredient(s): | 8 mg/g & nbsp; TERCONAZOLE |
| Administration Route(s): | VAGINAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0062-5356 |
| Labeler Name: | Ortho-McNeil-Janssen Pharmaceutical |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019964 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19910221 |
| Package NDC: | 0062-5356-01 |
| Package Description: | 20 g in 1 TUBE, WITH APPLICATOR (0062-5356-01) |
| NDC Code | 0062-5356-01 |
| Proprietary Name | Terazol 3 |
| Package Description | 20 g in 1 TUBE, WITH APPLICATOR (0062-5356-01) |
| Product NDC | 0062-5356 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TERCONAZOLE |
| Dosage Form Name | CREAM |
| Route Name | VAGINAL |
| Start Marketing Date | 19910221 |
| Marketing Category Name | NDA |
| Labeler Name | Ortho-McNeil-Janssen Pharmaceutical |
| Substance Name | TERCONAZOLE |
| Strength Number | 8 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Azole Antifungal [EPC],Azoles [Chemical/Ingredient] |